Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial

BACKGROUND: Patients with the metabolic syndrome are more likely to develop type 2 diabetes and may have an increased risk of cardiovascular disease (CVD) events.We aimed to establish whether CVD event rates were influenced by the metabolic syndrome as defined by the World Health Organisation (WHO),...

Descripción completa

Detalles Bibliográficos
Autores principales: Scott, Russell, Donoghoe, Mark, Watts, Gerald F, O'Brien, Richard, Pardy, Christopher, Taskinen, Marja-Riitta, Davis, Timothy ME, Colman, Peter G, Manning, Patrick, Fulcher, Gregory, Keech, Anthony C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286386/
https://www.ncbi.nlm.nih.gov/pubmed/22104275
http://dx.doi.org/10.1186/1475-2840-10-102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286386/
https://www.ncbi.nlm.nih.gov/pubmed/22104275
http://dx.doi.org/10.1186/1475-2840-10-102

Ejemplares similares